Matthias Bodenstedt Moon Lake Immunotherapeutics (MLTX) insider trading activity

Matthias Bodenstedt is Chief Financial Officer of MoonLake Immunotherapeutics. Currently has a direct ownership of 616,666 shares of MLTX, which is worth approximately $25.8 Million. The most recent transaction as insider was on Feb 27, 2025, when has been sold 95,763 shares (Class A ordinary shares, par value $0.0001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 617K

18.38% 3M change

18.38% 12M change

Total Value Held $25.8 Million

Matthias Bodenstedt Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 27 2025	BUY Grant, award, or other acquisition	-	95,763 Added 13.44%	616,666 Class A ordinary share...
Dec 20 2023	SELL Open market or private sale	$307,101 $58.34 p/Share	5,264 Reduced 1.0%	520,903 Class A ordinary share...
Dec 19 2023	SELL Open market or private sale	$5,610,265 $59.22 p/Share	94,736 Reduced 15.26%	526,167 Class A ordinary share...
Oct 01 2023	SELL Sale (or disposition) back to the issuer	-	62,972 Reduced 17.62%	294,473 Class C ordinary share...
Oct 01 2023	BUY Conversion of derivative security	-	62,972 Added 9.21%	620,903 Class A ordinary share...
Apr 05 2023	SELL Sale (or disposition) back to the issuer	-	557,931 Reduced 60.95%	357,445 Class C ordinary share...
Apr 05 2023	BUY Conversion of derivative security	-	557,931 Added 50.0%	557,931 Class A ordinary share...

Matthias Bodenstedt

Chief Financial Officer

Zug, V8

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MLTX shares.

Notify only if

Value

Insider Trading

Get notified when an Moon Lake Immunotherapeutics insider buys or sells MLTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to MoonLake Immunotherapeutics

Track Activities on MLTX

Account